UnitedHealth Group Inc. (UNH) shares have shown a notable reversal and upward movement following a period of bottoming out near the $240 support level, which the stock held twice recently. The stock, currently trading at a substantial discount to its 52-week high near $630, has attracted investor attention with some targeting a price range between $350 and $400 or higher by next year. This optimism is supported by the company's CEO purchasing $25 million worth of shares in May, signaling confidence in the stock's prospects. Additionally, the leveraged ETF on UNH (UNHG) has gained approximately 14% since the bottom, with speculation of the underlying stock reaching $282. Market activity indicates orderly trading with clear support and resistance levels, and the stock price has moved above recent highs. Other healthcare stocks like Eli Lilly (LLY) have also experienced gains amid this upward trend.